Theoretical implications of drug-induced adaptive regulation for a biogenic amine hypothesis of affective disorder.
D000818:Animals; D001679:Biogenic Amines / Q000378:metabolism*; D001923:Brain Chemistry / Q000187:drug effects; D002395:Catecholamines / Q000096:biosynthesis; D002421:Caudate Nucleus / Q000378:metabolism; D002540:Cerebral Cortex / Q000378:metabolism; D003863:Depression / Q000378:metabolism*; D003864:Depression, Chemical; D003891:Desipramine / Q000494:pharmacology; D004305:Dose-Response Relationship, Drug; D006624:Hippocampus / Q000378:metabolism; D006801:Humans; D007031:Hypothalamus / Q000378:metabolism; D008297:Male; D009411:Nerve Endings / Q000187:drug effects / Q000378:metabolism; D009474:Neurons / Q000378:metabolism; D051381:Rats; D012110:Reserpine / Q000494:pharmacology; D013268:Stimulation, Chemical; D009435:Synaptic Transmission; D014446:Tyrosine 3-Monooxygenase / Q000096:biosynthesis
D001679:Biogenic Amines; D002395:Catecholamines; D012110:Reserpine; D014446:Tyrosine 3-Monooxygenase; D003891:Desipramine